SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-014718
Filing Date
2021-06-14
Accepted
2021-06-14 16:08:43
Documents
8
Period of Report
2021-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20210610_8k.htm 8-K 20743
2 EXHIBIT 10.1 ex_256831.htm EX-10.1 564072
3 ex_256831img001.jpg GRAPHIC 100677
4 ex_256831img002.jpg GRAPHIC 98444
5 ex_256831img003.jpg GRAPHIC 121087
6 ex_256831img004.jpg GRAPHIC 91834
7 ex_256831img005.jpg GRAPHIC 101132
8 ex_256831img006.jpg GRAPHIC 77770
  Complete submission text file 0001437749-21-014718.txt   1400489
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 211014698
SIC: 2834 Pharmaceutical Preparations